cas 1449598-86-0|| where to buy 2-Chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

製品名:2-Chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

IUPAC Name:2-chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one

包装単位	有効在庫	価格（USD）
CM337294-1g	in stock	ȦȷȦ
CM337294-10g	in stock	Ʊɐɐƻ
CM337294-100g	in stock	ƋǲƋƻ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1449598-86-0 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:1449598-86-0; 分子式:C8H4ClFN2O; 融点:-; SMILESコード:O=C1C=C(Cl)N=C2N1C=C(F)C=C2; 密度:

: カタログ番号:CM337294; 分子量:198.58; 沸点:; MDL番号:MFCD28659052; 保管方法:

: Risdiplam; As the first approved small molecule splicing modifier drug, Risdiplam (Evrysdi) is granted approval by the European Commission to expand the EU marketing authorization. This extension now includes infants with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies from birth to below two months. Type 1 spinal muscular atrophy (SMA) is a rare, progressive neuromuscular disease and a leading genetic factor of infant mortality, that is caused by low levels of functional survival of motor neuron (SMN) protein. Risdiplam modifies SMN2 pre-messenger RNA splicing and increases levels of functional SMN protein in both the central nervous system and peripheral organs.